enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Athersys Jumps More Than 20% After FDA Approves ... - AOL

   www.aol.com/news/athersys-jumps-more-20-fda...

   Shares in Athersys, Inc. (ATHX) soared more than 20% in U.S. premarket trading after the biotech company announced that it was granted approval by the Food and Drug Administration (FDA) to start a ...

3. Athersys (ATHX) Upgraded to Strong Buy: Here's What You ...

   www.aol.com/news/athersys-athx-upgraded-strong...

   For premium support please call: 800-290-4726 more ways to reach us

4. Stock market news live updates: Stocks extend volatility ...

   www.aol.com/finance/stock-market-news-live...

   McDonald’s stock was mostly flat in morning trading, up slightly by 0.25% to $250.49 per share as of 11:32 a.m. E.T. 10:00 a.m. ET: US homebuying slows in the final month of 2021

5. Implied Volatility Surging for Athersys (ATHX) Stock Options

   www.aol.com/news/implied-volatility-surging...

   For premium support please call: 800-290-4726 more ways to reach us

6. Athersys, Inc. (ATHX) Upgraded to Buy: Here's Why - AOL

   www.aol.com/news/athersys-inc-athx-upgraded-buy...

   For premium support please call: 800-290-4726 more ways to reach us

7. Athersys (NASDAQ:ATHX) shareholders have endured a 34% loss ...

   www.aol.com/news/athersys-nasdaq-athx...

   For premium support please call: 800-290-4726 more ways to reach us

8. Frank Mottek - Wikipedia

   en.wikipedia.org/wiki/Frank_Mottek

   Frank Mottek is an American broadcast journalist known as “The Voice of Business News in Los Angeles” [citation needed] for his business reports on radio and television stations in Los Angeles, and hosting business news shows including "Mottek On Money."

9. Athersys (ATHX) Down as Ischemic Stroke Study Fails to ... - AOL

   www.aol.com/news/athersys-athx-down-ischemic...

   While a mid-stage/late-stage study evaluating Athersys' (ATHX) stem cell treatment for ischemic stroke misses out on its primary endpoint, top-line data shows evidence of therapeutic impact.